Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Pratt

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
Health Technology Assessment (Winchester, England)|November 7, 2019
Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCTMark T Drayson, Stella Bowcock, Tim Planche, et al.
Blood|August 27, 2010
The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivoVictoria J Weston, Ceri E Oldreive, Anna Skowronska, et al.
Disease Models & Mechanisms|September 24, 2015
T-cell number and subtype influence the disease course of primary chronic lymphocytic leukaemia xenografts in alymphoid miceCeri E Oldreive, Anna Skowronska, Nicholas J Davies, et al.
British Journal of Haematology|August 20, 2024
PembroWM: A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's MacroglobulinaemiaJaimal Kothari, Toby Eyre, Ali Rismani, et al.
Blood Advances|June 5, 2023
Uptake of long-chain fatty acids from the bone marrow suppresses CD8+ T-cell metabolism and function in multiple myelomaNancy Gudgeon, Hannah Giles, Emma L Bishop, et al.
British Journal of Haematology|July 4, 2014
Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage diseaseThet Thet Lin, Kevin Norris, Nicole H Heppel, et al.
Leukemia Research|November 25, 2010
CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLLAneela Majid, Thet Thet Lin, Giles Best, et al.
Blood|June 4, 2005
Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cellsKarl R N Baumforth, Joanne R Flavell, Gary M Reynolds, et al.
Clinical Medicine (London, England)|February 20, 2024
Extending the reach of expert amyloidosis care: A feasibility study exploring the staged implementation of a UK amyloidosis networkChern Hsiang Choy, Richard P Steeds, Jennifer Pinney, et al.
Haematologica|May 30, 2024
The glutamate/aspartate transporter EAAT1 is crucial for T-cell acute lymphoblastic leukemia proliferation and survivalVesna S Stanulović, Shorog Al Omair, Michelle A C Reed, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Health Technology Assessment (Winchester, England)|November 7, 2019
Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCTMark T Drayson, Stella Bowcock, Tim Planche, et al.
Blood|August 27, 2010
The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivoVictoria J Weston, Ceri E Oldreive, Anna Skowronska, et al.
Disease Models & Mechanisms|September 24, 2015
T-cell number and subtype influence the disease course of primary chronic lymphocytic leukaemia xenografts in alymphoid miceCeri E Oldreive, Anna Skowronska, Nicholas J Davies, et al.
British Journal of Haematology|August 20, 2024
PembroWM: A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's MacroglobulinaemiaJaimal Kothari, Toby Eyre, Ali Rismani, et al.
Blood Advances|June 5, 2023
Uptake of long-chain fatty acids from the bone marrow suppresses CD8+ T-cell metabolism and function in multiple myelomaNancy Gudgeon, Hannah Giles, Emma L Bishop, et al.
British Journal of Haematology|July 4, 2014
Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage diseaseThet Thet Lin, Kevin Norris, Nicole H Heppel, et al.
Leukemia Research|November 25, 2010
CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLLAneela Majid, Thet Thet Lin, Giles Best, et al.
Blood|June 4, 2005
Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cellsKarl R N Baumforth, Joanne R Flavell, Gary M Reynolds, et al.
Clinical Medicine (London, England)|February 20, 2024
Extending the reach of expert amyloidosis care: A feasibility study exploring the staged implementation of a UK amyloidosis networkChern Hsiang Choy, Richard P Steeds, Jennifer Pinney, et al.
Haematologica|May 30, 2024
The glutamate/aspartate transporter EAAT1 is crucial for T-cell acute lymphoblastic leukemia proliferation and survivalVesna S Stanulović, Shorog Al Omair, Michelle A C Reed, et al.
Pageof 14